VisioNova By Acer India | Acer India

Cortical Visual Impairment (CVI) is emerging as one of India’s most critical childhood health concerns, affecting 161 of every 100,000 children born. CVI occurs when the visual-processing areas of the brain are impaired, even though the eyes themselves may be structurally normal. Children with CVI struggle with visually guided tasks, learning, motor coordination, and daily functioning. Traditionally, therapy for CVI relies on bulky, expensive machines that require children to remain in hospitals for six to nine months, creating significant barriers for families—especially those from underserved regions.

To bridge this gap, Acer India partnered with Narayana Nethralaya under its Buds to Blossoms initiative to support the development and deployment of Acer VisioNova, a pioneering digital vision therapy platform and the first of its kind designed to seamlessly extend treatment from hospital to home. VisioNova was conceptualized as a companion to clinical therapy—delivering standard-of-care interventions across multiple care settings without compromising on therapeutic quality.

Within hospital environments, VisioNova is powered through Acer Interactive Flat Panels, enabling therapists to conduct immersive, large-format visual stimulation and guided therapy sessions in a controlled clinical setting. These are supported by Acer Veriton desktop systems, which serve as the core clinical workstations—ensuring stable performance, accurate visual rendering, and consistent delivery of therapy protocols during in-hospital treatment and assessment.
Extending this continuum of care beyond the hospital, Acer has contributed hundreds of tablets, enabling Narayana Nethralaya to launch a structured home-therapy model. Through a small, refundable deposit, families can access VisioNova on tablets, allowing children to continue therapy remotely under expert supervision. This approach removes financial and logistical barriers, significantly reducing the need for repeated hospital visits while ensuring uninterrupted care from the safety and comfort of home.

VisioNova itself represents a breakthrough in modern vision therapy. It integrates structured digital modules that address perceptual skills, visual memory, eye movements, and sensorimotor development. Activities such as tachistoscope-based perceptual training, power-wheel exercises, saccadic eye-movement therapy, eye–hand coordination tasks, and adaptive memory-building modules help strengthen functional vision. Designed for children as well as adults, the platform supports developmental delays, amblyopia management, neurological rehabilitation, and occupational visual enhancement. Its reproducible clinical parameters ensure consistency across devices, while its interactive design improves engagement and adherence—key factors in long-term therapeutic success.
By enabling a true hospital-to-home care continuum, VisioNova overcomes the limitations of traditional therapy, making high-quality vision intervention affordable, scalable, and inclusive. Children who once required prolonged hospital stays can now progress at home with ongoing clinical oversight, while hospitals can extend their reach to communities previously underserved by specialty care.

Together, Acer and Narayana Nethralaya are redefining how India approaches visual rehabilitation—bringing therapy to the child rather than the child to the therapy. VisioNova stands as a powerful example of technology with purpose, reflecting Acer’s commitment to meaningful innovation and social impact, and offering children affected by CVI a future filled with independence, confidence, and possibility.